Search - tctmd.com

Displaying 81 - 100 of 2679

Sort: Relevancy | Date

News Conference News EACTS 2025

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

Yael L. Maxwell

October 13, 2025

News Daily News

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

Todd Neale

October 07, 2025

News Daily News

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

Todd Neale

October 03, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

L.A. McKeown

October 03, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Daily News

Recognize and Enable Care for Post-MI Psychological Distress: AHA

L.A. McKeown

October 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Conference News HFSA 2025

Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF

Yael L. Maxwell

September 29, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Daily News

AI Tool Supports Mammograms as Method to Screen Women for CV Risk

Caitlin E. Cox

September 18, 2025

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Daily News

Nonatherosclerotic Causes of MI Common in Younger Patients

L.A. McKeown

September 17, 2025

News Conference News ESC 2025

Lift as You Rise: Women in Cardiology Meet in Madrid to Talk Change

Caitlin E. Cox

September 11, 2025

News Conference News ESC 2025

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

Todd Neale

August 31, 2025

News Conference News ESC 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Michael O'Riordan

August 31, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

PREVENT Equations in BP Guidelines Means Better Treatment, the ACC/AHA Say

Yael L. Maxwell

August 28, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

Advertisement

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Evolocumab Wins for Primary Prevention in VESALIUS-CV

Risk Factors Present in Nearly All Patients Who Develop CVD

Recognize and Enable Care for Post-MI Psychological Distress: AHA

TCTMD’s Top 10 Most Popular Stories for September 2025

September 2025 Dispatch for the CV Team

Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

AI Tool Supports Mammograms as Method to Screen Women for CV Risk

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Nonatherosclerotic Causes of MI Common in Younger Patients

Lift as You Rise: Women in Cardiology Meet in Madrid to Talk Change

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

PREVENT Equations in BP Guidelines Means Better Treatment, the ACC/AHA Say

August 2025 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content